Early Access — free while we kick the tires
EdgarHawk

McNealy Sean

Co-Founder and President

Director Officer 10% Owner
3 filings analyzed · 1 company · Latest 2025-06-06

Companies

Company Buys Sells Direction
Abacus Life, Inc. ABX 1 2 Net selling

Activity

June 2025
Buy
86,207 shares
$497,759
Significance 7/10

Co-Founder McNealy buys 86,207 shares at $5.77; stock down 48.4% from $11.73 high, yet cluster pattern emerges with 2 other insiders buying in past 14 days

Sean McNealy, Co-Founder and President, purchased 86,207 shares at $5.77 on 2025-06-04, bringing his holdings to 12,455,707 shares. The purchase occurs after a severe drawdown: ABL has fallen 48.4% from its 52-week high of $11.73 and is down 26.7% over the past 30 days. McNealy's same-ticker history at ABL shows a 3-of-3 well-timed pattern—his prior two sales in late 2024 each preceded further declines, and his prior buy in November 2023 captured a +99.4% 90-day gain. However, the company posted negative full-year net income despite strong revenue growth of 68.6% year-over-year and current quarterly profitability of $4.6M on $44.1M revenue. The meaningful signal here is not isolated conviction but the cluster: 2 additional insiders also purchased within the past 14 days, suggesting coordinated or near-simultaneous leadership confidence at depressed levels. This cluster activity, combined with McNealy's demonstrated timing acuity at this ticker and the sharp price decline, warrants investor attention to whether management believes the drawdown is reversible.

December 2024
2024-12-23 Abacus Life, Inc. ABX
medium
Sell
75,800 shares
$606,400
Significance 5/10

McNealy sells 75,800 shares of ABL at $8.00 (12-20-2024), maintaining 12.36M shares; stock -37.4% from 52-week high of $12.47

McNealy, Co-Founder and President, sold 75,800 shares at $8.00 for $606,400, reducing holdings by 0.6% to 12.36M shares. The transaction occurs after ABL stock has declined 26.4% over 90 days and 37.4% from its 52-week high of $12.47, though the stock has recovered +3.3% over the past 30 days. His prior sale at this ticker on 2024-11-21 showed a 30-day return of -3.5%, and his historical prior purchase at ABL on 2023-11-16 yielded a 90-day return of +99.4%, demonstrating a mixed pattern at this specific security. The company is growing revenue at +48.5% annually but remains unprofitable, with a net loss of $5,125,055 on revenue of $28,148,491 in the latest quarter, and carries a P/E of 45.88. The modest sale size relative to total holdings and the recent stock recovery provide limited clarity on insider conviction regarding ABL's prospects.

November 2024
2024-11-25 Abacus Life, Inc. ABX
high
Sell
156,250 shares
$1,250,000
Significance 6/10

Co-founder Sean McNealy sold 156,250 shares of ABL at $8.00 on 2024-11-21; stock now -38.5% from 52-week high.

Sean McNealy, Co-Founder and President, sold 156,250 shares for $1,250,000.00, reducing his holdings from 12,593,550 to 12,437,300 shares (a -1.2% reduction). The sale occurred at $8.00 per share; the stock has since declined to $7.67 and is -38.5% from its 52-week high of $12.47, with a -15.1% drop over 30 days and -25.8% over 90 days. While McNealy's cross-ticker track record shows strong timing (100% win rate with +99.4% average 90-day returns on prior buys), his single prior buy at ABL on 2023-11-16 was also well-timed (+30.5% at 30 days, +99.4% at 90 days). The current sell follows a period of material stock weakness and coincides with negative quarterly fundamentals: net income of -$5,125,055 against revenue of $28,148,491, though annual revenue growth of +48.5% indicates underlying business expansion. The timing of this sale relative to the recent price decline and the divergence between strong growth metrics and current losses warrants deeper examination of the company's path to profitability and near-term operational outlook.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access